Atorvastatin in moderat active Crohns disease.
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2011
At a glance
- Drugs Atorvastatin (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 23 Jul 2011 New trial record
- 19 Oct 2007 New source identified and integrated (NCT00454545, 010-02) (ClinicalTrials.gov: US National Institutes of Health).
- 19 Oct 2007 Actual end date (October 2007) added as reported by ClinicalTrials.gov.